Issued Patents 2022
Showing 1–12 of 12 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11530219 | Ligands to cereblon (CRBN) | Tinghu Zhang, Eric Fischer, Zhixiang He, Guangyan Du, Katherine Donovan +2 more | 2022-12-20 |
| 11505560 | Heterobifunctional compounds with improved specificity | Radoslaw Nowak, Eric Fischer, Tinghu Zhang, Zhixiang He, Brian Groendyke | 2022-11-22 |
| 11447467 | Compounds for the degradation of STK4 and treatment of hematologic malignancies | Sara Jean Buhrlage, Kenneth C. Anderson, Teru Hideshima, Xiaoxi Liu | 2022-09-20 |
| 11325910 | Inhibitors of cyclin-dependent kinases | Tinghu Zhang, Nicholas Paul Kwiatkowski | 2022-05-10 |
| 11306070 | Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof | Tinghu Zhang, Baishan Jiang, Nicholas Paul Kwiatkowski | 2022-04-19 |
| 11285158 | Uses of pyrimidopyrimidinones as SIK inhibitors | David E. Fisher, Nisma Mujahid, Ryo Murakami, Yanke Liang, Hwan Geun Choi | 2022-03-29 |
| 11285144 | Use of CDK8 inhibitors to treat diseases of inflammation and autoimmunity | Thomas Sundberg, Alykhan Shamji, Ramnik Xavier, Liv Helena Johannessen, Bernard Khor +1 more | 2022-03-29 |
| 11279707 | NEK inhibitors and methods of use | Quan Cai, Tinghu Zhang | 2022-03-22 |
| 11254682 | Small molecule myristate inhibitors of Bcr-abl and methods of use | Jianming Zhang, Barun Okram, Xianming Deng, Jae Won Chang, Amy Wojciechowski | 2022-02-22 |
| 11248007 | Inhibitors of MALT1 and uses thereof | David A. Scott, John Hatcher, Ari M. Melnick, Lorena Fontan Gabas | 2022-02-15 |
| 11247991 | Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use | Tinghu Zhang, Calla M. Olson, Yanke Liang, Nicholas Paul Kwiatkowski | 2022-02-15 |
| 11241435 | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis | Marc Wein, Henry M. Kronenberg, Thomas Sundberg, Ramnik Xavier, Yanke Liang +2 more | 2022-02-08 |